Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Assessing Marine Microbial Induced Corrosion at Santa Catalina Island, California.

Ramírez GA, Hoffman CL, Lee MD, Lesniewski RA, Barco RA, Garber A, Toner BM, Wheat CG, Edwards KJ, Orcutt BN.

Front Microbiol. 2016 Oct 25;7:1679. eCollection 2016.

2.

Archaeal and bacterial diversity in an arsenic-rich shallow-sea hydrothermal system undergoing phase separation.

Price RE, Lesniewski R, Nitzsche KS, Meyerdierks A, Saltikov C, Pichler T, Amend JP.

Front Microbiol. 2013 Jul 9;4:158. doi: 10.3389/fmicb.2013.00158. eCollection 2013.

3.

Genome-enabled transcriptomics reveals archaeal populations that drive nitrification in a deep-sea hydrothermal plume.

Baker BJ, Lesniewski RA, Dick GJ.

ISME J. 2012 Dec;6(12):2269-79. doi: 10.1038/ismej.2012.64. Epub 2012 Jun 14.

4.

The metatranscriptome of a deep-sea hydrothermal plume is dominated by water column methanotrophs and lithotrophs.

Lesniewski RA, Jain S, Anantharaman K, Schloss PD, Dick GJ.

ISME J. 2012 Dec;6(12):2257-68. doi: 10.1038/ismej.2012.63. Epub 2012 Jun 14.

5.

ABT-869, a multitargeted receptor tyrosine kinase inhibitor, reduces tumor microvascularity and improves vascular wall integrity in preclinical tumor models.

Jiang F, Albert DH, Luo Y, Tapang P, Zhang K, Davidsen SK, Fox GB, Lesniewski R, McKeegan EM.

J Pharmacol Exp Ther. 2011 Jul;338(1):134-42. doi: 10.1124/jpet.110.178061. Epub 2011 Apr 19.

PMID:
21505059
6.

A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax).

Lam LT, Lu X, Zhang H, Lesniewski R, Rosenberg S, Semizarov D.

Mol Cancer Ther. 2010 Nov;9(11):2943-50. doi: 10.1158/1535-7163.MCT-10-0427. Epub 2010 Sep 9.

7.

Recombinant kringle 5 from plasminogen antagonises hepatocyte growth factor-mediated signalling.

Ansell PJ, Zhang H, Davidson DJ, Harlan JE, Xue J, Brodjian S, Lesniewski R, McKeegan E.

Eur J Cancer. 2010 Mar;46(5):966-73. doi: 10.1016/j.ejca.2009.12.026. Epub 2010 Jan 12.

PMID:
20061137
8.

Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.

Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF.

Appl Environ Microbiol. 2009 Dec;75(23):7537-41. doi: 10.1128/AEM.01541-09. Epub 2009 Oct 2.

9.

Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition.

Warder SE, Tucker LA, McLoughlin SM, Strelitzer TJ, Meuth JL, Zhang Q, Sheppard GS, Richardson PL, Lesniewski R, Davidsen SK, Bell RL, Rogers JC, Wang J.

J Proteome Res. 2008 Nov;7(11):4807-20. doi: 10.1021/pr800388p. Epub 2008 Oct 2.

PMID:
18828628
10.

The potency of erythropoietin-mimic antibodies correlates inversely with affinity.

Lacy SE, DeVries PJ, Xie N, Fung E, Lesniewski RR, Reilly EB.

J Immunol. 2008 Jul 15;181(2):1282-7.

11.

Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation.

Tucker LA, Zhang Q, Sheppard GS, Lou P, Jiang F, McKeegan E, Lesniewski R, Davidsen SK, Bell RL, Wang J.

Oncogene. 2008 Jun 26;27(28):3967-76. doi: 10.1038/onc.2008.14. Epub 2008 Feb 11.

PMID:
18264137
12.

A potent erythropoietin-mimicking human antibody interacts through a novel binding site.

Liu Z, Stoll VS, Devries PJ, Jakob CG, Xie N, Simmer RL, Lacy SE, Egan DA, Harlan JE, Lesniewski RR, Reilly EB.

Blood. 2007 Oct 1;110(7):2408-13. Epub 2007 Jul 9.

PMID:
17620453
13.

Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.

Olejniczak ET, Van Sant C, Anderson MG, Wang G, Tahir SK, Sauter G, Lesniewski R, Semizarov D.

Mol Cancer Res. 2007 Apr;5(4):331-9.

14.

Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids.

Wang GT, Mantei RA, Kawai M, Tedrow JS, Barnes DM, Wang J, Zhang Q, Lou P, Garcia LA, Bouska J, Yates M, Park C, Judge RA, Lesniewski R, Sheppard GS, Bell RL.

Bioorg Med Chem Lett. 2007 May 15;17(10):2817-22. Epub 2007 Feb 25.

PMID:
17350258
15.

Endothelin signaling in osteoblasts: global genome view and implication of the calcineurin/NFAT pathway.

Van Sant C, Wang G, Anderson MG, Trask OJ, Lesniewski R, Semizarov D.

Mol Cancer Ther. 2007 Jan;6(1):253-61.

16.

Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.

Sheppard GS, Wang J, Kawai M, Fidanze SD, BaMaung NY, Erickson SA, Barnes DM, Tedrow JS, Kolaczkowski L, Vasudevan A, Park DC, Wang GT, Sanders WJ, Mantei RA, Palazzo F, Tucker-Garcia L, Lou P, Zhang Q, Park CH, Kim KH, Petros A, Olejniczak E, Nettesheim D, Hajduk P, Henkin J, Lesniewski R, Davidsen SK, Bell RL.

J Med Chem. 2006 Jun 29;49(13):3832-49.

PMID:
16789740
17.

Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.

Kawai M, BaMaung NY, Fidanze SD, Erickson SA, Tedrow JS, Sanders WJ, Vasudevan A, Park C, Hutchins C, Comess KM, Kalvin D, Wang J, Zhang Q, Lou P, Tucker-Garcia L, Bouska J, Bell RL, Lesniewski R, Henkin J, Sheppard GS.

Bioorg Med Chem Lett. 2006 Jul 1;16(13):3574-7. Epub 2006 May 2.

PMID:
16632353
18.

Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78.

Davidson DJ, Haskell C, Majest S, Kherzai A, Egan DA, Walter KA, Schneider A, Gubbins EF, Solomon L, Chen Z, Lesniewski R, Henkin J.

Cancer Res. 2005 Jun 1;65(11):4663-72.

19.

Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.

Haviv F, Bradley MF, Kalvin DM, Schneider AJ, Davidson DJ, Majest SM, McKay LM, Haskell CJ, Bell RL, Nguyen B, Marsh KC, Surber BW, Uchic JT, Ferrero J, Wang YC, Leal J, Record RD, Hodde J, Badylak SF, Lesniewski RR, Henkin J.

J Med Chem. 2005 Apr 21;48(8):2838-46.

PMID:
15828822
20.

3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.

Sheppard GS, Wang J, Kawai M, BaMaung NY, Craig RA, Erickson SA, Lynch L, Patel J, Yang F, Searle XB, Lou P, Park C, Kim KH, Henkin J, Lesniewski R.

Bioorg Med Chem Lett. 2004 Feb 23;14(4):865-8.

PMID:
15012983
21.

Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.

Wang J, Sheppard GS, Lou P, Kawai M, BaMaung N, Erickson SA, Tucker-Garcia L, Park C, Bouska J, Wang YC, Frost D, Tapang P, Albert DH, Morgan SJ, Morowitz M, Shusterman S, Maris JM, Lesniewski R, Henkin J.

Cancer Res. 2003 Nov 15;63(22):7861-9.

22.

Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese.

Wang J, Sheppard GS, Lou P, Kawai M, Park C, Egan DA, Schneider A, Bouska J, Lesniewski R, Henkin J.

Biochemistry. 2003 May 6;42(17):5035-42.

PMID:
12718546
23.

Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly.

Wang J, Lou P, Lesniewski R, Henkin J.

Anticancer Drugs. 2003 Jan;14(1):13-9.

PMID:
12544254
24.

Hepatitis C virus core and E2 protein expression in transgenic mice.

Pasquinelli C, Shoenberger JM, Chung J, Chang KM, Guidotti LG, Selby M, Berger K, Lesniewski R, Houghton M, Chisari FV.

Hepatology. 1997 Mar;25(3):719-27.

PMID:
9049225
25.
26.

Persistent hepatitis C virus infection after liver transplantation: clinical and virological features.

Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, Gown A, Frank I, Perkins JD, Carithers RL Jr.

Hepatology. 1995 Jul;22(1):1-9.

PMID:
7601397
27.

Hepatitis C--associated glomerular disease in liver transplant recipients.

Davis CL, Gretch DR, Perkins JD, Harris AW, Wener MH, Alpers CE, Lesniewski R, Lee W, dela Rosa C, Johnson RJ, et al.

Liver Transpl Surg. 1995 May;1(3):166-75.

28.

Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia.

Lesniewski R, Okasinski G, Carrick R, Van Sant C, Desai S, Johnson R, Scheffel J, Moore B, Mushahwar I.

J Med Virol. 1995 Apr;45(4):415-22.

PMID:
7545212
29.

Expression of HCV envelope proteins and the serological utility of the anti-E2 immune response.

Lesniewski RR, Watanabe S, Devare SG.

Princess Takamatsu Symp. 1995;25:129-37.

PMID:
8875617
30.

E2 and NS5: new antigens for detection of hepatitis C virus antibodies.

Zaaijer HL, Vallari DS, Cunningham M, Lesniewski R, Reesink HW, van der Poel CL, Lelie PN.

J Med Virol. 1994 Dec;44(4):395-7.

PMID:
7534821
31.

Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection.

Lau GK, Lesniewski R, Johnson RG, Davis GL, Lau JY.

J Med Virol. 1994 Sep;44(1):1-4. Erratum in: J Med Virol 1995 Apr;45(4):475-6.

PMID:
7528259
32.

Detection and distribution of hepatitis C-specific antigens in naturally infected liver.

Blight K, Lesniewski RR, LaBrooy JT, Gowans EJ.

Hepatology. 1994 Sep;20(3):553-7.

PMID:
7521312
33.

Optimization for the detection of hepatitis C virus antigens in the liver.

González-Peralta RP, Fang JW, Davis GL, Gish R, Tsukiyama-Kohara K, Kohara M, Mondelli MU, Lesniewski R, Phillips MI, Mizokami M, et al.

J Hepatol. 1994 Jan;20(1):143-7. Erratum in: J Hepatol 1994 Jun;20(6):848.

PMID:
7515407
34.

Immunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathology.

Blight K, Rowland R, Hall PD, Lesniewski RR, Trowbridge R, LaBrooy JT, Gowans EJ.

Am J Pathol. 1993 Dec;143(6):1568-73.

35.

Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants.

Lesniewski RR, Boardway KM, Casey JM, Desai SM, Devare SG, Leung TK, Mushahwar IK.

J Med Virol. 1993 Jun;40(2):150-6.

PMID:
7689636
36.

Risk of liver disease in HCV-seropositive kidney transplant recipients.

Rohr MS, Lesniewski RR, Rubin CA, Johnson RG, Heise ER, McDonald JC, Adams PL.

Ann Surg. 1993 May;217(5):512-6; discussion 516-7.

37.

Localisation of hepatitis C virus proteins in infected liver tissue by immunofluorescence.

Blight K, Lesniewski R, LaBrooy J, Trowbridge R, Gowans E.

Gastroenterol Jpn. 1993 May;28 Suppl 5:55-8.

PMID:
7689508
38.

Lack of protective immunity against reinfection with hepatitis C virus.

Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, et al.

Science. 1992 Oct 2;258(5079):135-40.

PMID:
1279801
39.

Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.

Bresters D, Cuypers HT, Reesink HW, Schaasberg WP, van der Poel CL, Mauser-Bunschoten EP, Houghton M, Choo QL, Kuo G, Lesniewski R, et al.

Vox Sang. 1992;62(4):213-7.

PMID:
1379394
40.

Localization of hepatitis C virus antigen(s) by immunohistochemistry on fixed-embedded liver tissue.

Infantolino D, Chiaramonte M, Zanetti AR, Lesniewski RR, Bonino F.

Arch Virol Suppl. 1992;4:191-5.

PMID:
1280504
41.

Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term-studied patients with posttransfusion hepatitis C.

Mattsson L, Gutierrez RA, Dawson GJ, Lesniewski RR, Mushahwar LK, Weiland O.

Scand J Gastroenterol. 1991 Dec;26(12):1257-62.

PMID:
1722348
42.

IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis.

Chau KH, Dawson GJ, Mushahwar IK, Gutierrez RA, Johnson RG, Lesniewski RR, Mattsson L, Weiland O.

J Virol Methods. 1991 Dec;35(3):343-52.

PMID:
1667792
43.

Detection of the hepatitis C virus genome in acute and chronic experimental infection in chimpanzees.

Schlauder GG, Leverenz GJ, Amann CW, Lesniewski RR, Peterson DA.

J Clin Microbiol. 1991 Oct;29(10):2175-9.

44.

Detection of antibodies to hepatitis C virus in U.S. blood donors.

Dawson GJ, Lesniewski RR, Stewart JL, Boardway KM, Gutierrez RA, Pendy L, Johnson RG, Alcalde X, Rote KV, Devare SG, et al.

J Clin Microbiol. 1991 Mar;29(3):551-6.

45.

Localization of hepatitis C virus (HCV) antigen by immunohistochemistry on fixed-embedded liver tissue.

Infantolino D, Bonino F, Zanetti AR, Lesniewski RR, Barbazza R, Chiaramonte M.

Ital J Gastroenterol. 1990 Aug;22(4):198-9.

PMID:
1720059
46.

Enumeration and Isolation of Mesophilic Anaerobic Sporeformers from Cannery Post-Processing Equipment.

Lake DE, Lesniewski RS, Anderson JE, Graves RR, Bremser JF.

J Food Prot. 1985 Sep;48(9):794-798. doi: 10.4315/0362-028X-48.9.794.

PMID:
30939682
47.

Post-Processing Spoilage of Low-Acid Canned Foods by Mesophilic Anaerobic Sporeformers.

Lake DE, Graves RR, Lesniewski RS, Anderson JE.

J Food Prot. 1985 Mar;48(3):221-226. doi: 10.4315/0362-028X-48.3.221.

PMID:
30939651
48.

Purine nucleoside and purine base concentrations in bovine thyroid and plasma.

McMahon KK, Lesniewski RR, Fischer AG.

Int J Biochem. 1983;15(7):947-52.

PMID:
6884570

Supplemental Content

Loading ...
Support Center